Remove Accountability Remove Life Sciences Remove Pharmaceuticals Remove Prevention
article thumbnail

Digiceuticals: Driving Growth Through Digital Health Services

HIT Consultant

Subhro Mallik, SVP & Head of Life Sciences at Infosys. The new normal has thrown up opportunities as well as risks for pharmaceutical companies. The application of digital technologies in pharmaceuticals – digiceuticals – is a promising way forward. There was tremendous interest in telemedicine before 2020.

article thumbnail

Is making mRNA vaccines for infectious diseases profitable?

Healthcare ECONOMIST

The figure below shows that as the Delta and Omicron variants spread in the fall of 2021, COVID-19 vaccines prevented significant number of deaths according to Vox. Despite these positive impacts, a number of political commentators have accused pharmaceutical companies of profiteering. A study by Ahuja et al. A study by Ahuja et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Wasted: $1 of Every $4 Spent on Health Care In America

Health Populi

Thus, administrative complexity, which includes billing and coding waste, and physician time spent reporting on quality measures, accounted for the largest component of waste in American health care. Pricing failure as a waste-factor accounted for nearly another third of total waste in U.S. medical spending. health care. health care.

article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

” I’ve pulled out a few of the data points that speak to me about population health, prevention and early diagnosis (or lack thereof), and alarm bells on women’s health — notably, young women and girls. Women thus accounted for one-third of ADHD prescriptions as of December 2022.

article thumbnail

From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology

Health Advances

Despite this growth, mRNA vaccine pipeline assets are still dominated by first mover and early innovators Moderna, CureVac, and BioNTech, who account for more than 50% of all advanced mRNA vaccine pipeline assets. Figure 1: Development of mRNA Vaccine Pipeline by Stage and Year, and Pharmaceutical Companies with Advanced Pipeline.

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

Health Populi’s Hot Points: The issue of drug and vaccine pricing for COVID-19 prevention and treatments has been under the media microscope since the start of the pandemic. Gallup and West Health polled 1,016 U.S. adults 18 and older, in English and Spanish, in May 2020. bn to $32.8 bn between 2019 and 2015 (Part D) and from $4.8